GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioage Labs Inc (NAS:BIOA) » Definitions » Inventories, Inventories Adjustments

BIOA (Bioage Labs) Inventories, Inventories Adjustments : $0.00 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bioage Labs Inventories, Inventories Adjustments?

Bioage Labs's Inventories, Inventories Adjustments for the quarter that ended in Jun. 2024 was $0.00 Mil.


Bioage Labs Inventories, Inventories Adjustments Historical Data

The historical data trend for Bioage Labs's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioage Labs Inventories, Inventories Adjustments Chart

Bioage Labs Annual Data
Trend Dec22 Dec23
Inventories, Inventories Adjustments
- -

Bioage Labs Quarterly Data
Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
Inventories, Inventories Adjustments Get a 7-Day Free Trial - - - - -

Bioage Labs Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.


Bioage Labs Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
1445A South 50th Street, Richmond, CA, USA, 94804
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. Its Products are Azelaprag (BGE-105), an apelin receptor APJ agonist that increases weight loss and improves body composition combined with incretin drugs. and BGE-100 is targeting metabolic diseases and neuroinflammation.

Bioage Labs Headlines

From GuruFocus